ReWalk Robotics Ltd. (NASDAQ:RWLK) Files An 8-K Shareholder Director Nominations
Item 5.08 Shareholder Director Nominations.

The information in Item 8.01 below is incorporated by reference into this Item 5.08.

Item 8.01 Other Information.

On March 13, 2018, the board of directors of ReWalk Robotics Ltd. (the “Company,” “we” or “us”) set the date of our 2018 Annual Meeting of Shareholders as April 30, 2018. Because this date is more than 30 days from the anniversary of the 2017 Annual Meeting of Shareholders, updated deadlines apply for submission of shareholder proposals to be considered for inclusion in our proxy materials for the 2018 Annual Meeting of Shareholders.

Shareholders who wish to have a proposal considered for inclusion in the Company’s proxy materials for the 2018 Annual Meeting of Shareholders to Rule 14a-8 under the Securities Exchange Act of 1934, as amended (“Rule 14a-8”), must ensure that such proposal is received on or before March 23, 2018 at our principal executive offices located at ReWalk Robotics Ltd., 3 Hatnufa Street, Floor 6, P.O.B. 161, Yokneam Ilit 20692, Israel, Attention: Chief Financial Officer. We have determined this to be a reasonable deadline for submission of shareholder proposals before we begin to print and mail our definitive proxy materials for the 2018 Annual Meeting of Shareholders. This effectively extends the deadline disclosed in our definitive proxy statement on Schedule 14A filed with the Securities and Exchange Commission in connection with the 2017 Annual Meeting of Shareholders.

In accordance with the requirements of Israeli law and our Articles of Association, shareholders who wish to bring business before the 2018 Annual Meeting of Shareholders other than to Rule 14a-8, including director nominations, must ensure that written notice of such proposal is received at ReWalk Robotics Ltd., 3 Hatnufa Street, Floor 6, P.O.B. 161, Yokneam Ilit 20692, Israel, Attention: Chief Financial Officer on or before March 23, 2018.

About ReWalk Robotics Ltd. (NASDAQ:RWLK)

ReWalk Robotics Ltd. is a medical device company. The Company is engaged in designing, developing and commercializing exoskeletons that allow wheelchair-bound individuals with mobility impairments or other medical conditions the ability to stand and walk. The Company offers ReWalk, an exoskeleton that uses its tilt-sensor technology, and an on-board computer and motion sensors to drive motorized legs that power movement. The Company’s ReWalk designs focus on people with paraplegia, a spinal cord injury resulting in complete or incomplete paralysis of the legs, who have the use of their upper bodies and arms. The Company offers various products, which include ReWalk Personal and ReWalk Rehabilitation. The Company’s ReWalk Personal is designed for use by individuals at home and in their communities, and is custom-fit for each user. The Company’s ReWalk Rehabilitation is designed for the clinical rehabilitation environment where it provides exercise and therapy.